Illumina (NASDAQ:ILMN) Director Daniel Bradbury sold 2,100 shares of the stock on the open market in a transaction dated Tuesday, July 8th. The shares were sold at an average price of $172.89, for a total value of $363,069.00. Following the sale, the director now directly owns 12,466 shares in the company, valued at approximately $2,155,247. Illumina, Inc. (NASDAQ:ILMN) stock performance was 2.51% in last session and finished the day at $175.23. Traded volume was 1.77million shares in the last session and the average volume of the stock remained 1.78million shares. The beta of the stock remained 0.55. Illumina, Inc. (NASDAQ:ILMN) insider ownership is 1.30%.

Raptor Pharmaceutical Corp. (NASDAQ:RPTP) Director Llew Keltner sold 10,000 shares of the stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $11.21, for a total transaction of $112,100.00. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) rose 6.43 percent to $10.92 Wednesday on volume of 1.01million shares. The intra-day range of the stock was $10.13 to $11.07. Raptor Pharmaceutical Corp. (NASDAQ:RPTP) has a market capitalization of $684.30million.

Stryker (NYSE:SYK) Director Ronda E. Stryker sold 7,000 shares of the company’s stock on the open market in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $85.19, for a total value of $596,330.00. Following the completion of the sale, the director now directly owns 174,605 shares in the company, valued at approximately $14,874,600. Stryker Corporation (NYSE:SYK)’s stock on July 09, 2014 reported a increase of 0.06% to the closing price of $83.98. Its fifty two weeks range is $65.48 -$86.93. The total market capitalization recorded $31.74billion. The overall volume in the last trading session was 951,837.00million shares. In its share capital, SYK has 379.09million outstanding shares.

United Therapeutics (NASDAQ:UTHR) CEO Martine A. Rothblatt sold 3,833 shares of the company’s stock on the open market in a transaction that occurred on Thursday, June 26th. The stock was sold at an average price of $87.23, for a total value of $334,352.59. Following the transaction, the chief executive officer now directly owns 140 shares in the company, valued at approximately $12,212. On Wednesday, shares of United Therapeutics Corporation (NASDAQ:UTHR) advanced 0.19% to close the day at $93.16. Company return on investment (ROI) is 11.80% and its monthly performance is recorded as -3.73%. United Therapeutics Corporation (NASDAQ:UTHR) quarterly revenue growth is -1.32%.

CareFusion (NYSE:CFN) Insider Thomas J. Leonard unloaded 1,250 shares of CareFusion stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $45.47, for a total value of $56,837.50. Following the sale, the insider now directly owns 32,053 shares in the company, valued at approximately $1,457,450. CareFusion Corporation (NYSE:CFN) stock performance was 0.38% in last session and finished the day at $44.72. Traded volume was 643,111.00million shares in the last session and the average volume of the stock remained 1.64million shares. The beta of the stock remained 0.93. CareFusion Corporation (NYSE:CFN) insider ownership is 0.20%.